Pharmacogenomics of Lithium Response in Bipolar Disorder

Pharmacogenomics of Lithium Response in Bipolar Disorder

Despite being the most widely studied mood stabilizer, researchers have not confirmed a mechanism for lithium’s therapeutic efficacy in Bipolar Disorder (BD). Pharmacogenomic applications may be clinically useful in the future for identifying lithium-responsive patients and facilitating personalized...

Full description

Bibliographic Details
Main Authors: Courtney M. Vecera, Gabriel R. Fries, Lokesh R. Shahani, Jair C. Soares, Rodrigo Machado-Vieira
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pharmaceuticals
Subjects:
pharmacogenomics
bipolar disorder
lithium
personalized medicine
predictive models
Genome-Wide Association Study (GWAS)
Online Access:https://www.mdpi.com/1424-8247/14/4/287

Internet

https://www.mdpi.com/1424-8247/14/4/287

Similar Items